Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol vs Oxycodone on GI Transit
NCT01500317Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- May 2011
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tapentadol in pain (3 arms), sponsored by Mayo Clinic. Primary endpoints: Colonic Transit, Geometric Center at 24 Hours and Gastric Emptying Half-time (t1/2) at 24 Hours. Started May 2011; status: completed.
02
Drugs
tapentadol
03
Conditions
pain
Beyond the preview
Go deeper on NCT01500317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01500317.